{"id":"W2151730005","doi":"10.1016/s1470-2045(09)70311-0","title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","year":2009,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":1974,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; Cetuximab; Head and neck cancer; Clinical endpoint; Radiation therapy; Rash; Internal medicine; Oncology; Head and neck squamous-cell carcinoma; Randomized controlled trial; Surgery; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}